Definitions
Sorry, no definitions found. You may find more data at trastuzumab.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Trastuzumab.
Examples
-
* The drug is also known by its pharmacological name Trastuzumab; the “ab” suffix is used to denote the fact that this is an antibody.
The Emperor of All Maladies Siddhartha Mukherjee 2010
-
* The drug is also known by its pharmacological name Trastuzumab; the “ab” suffix is used to denote the fact that this is an antibody.
The Emperor of All Maladies Siddhartha Mukherjee 2010
-
* The drug is also known by its pharmacological name Trastuzumab; the “ab” suffix is used to denote the fact that this is an antibody.
The Emperor of All Maladies Siddhartha Mukherjee 2010
-
The Karmanos Cancer Institute is enrolling patients in a Phase II clinical trial to determine the safety of a new breast cancer drug called Trastuzumab-DM1.
Freep.com - RSS 2008
-
Despite clinical success with the use of targeted therapies, such as Trastuzumab, only up to 35% of Her2 positive patients initially respond.
BioMed Central - Latest articles Fiona Foster 2009
-
Trastuzumab is generally well-tolerated and, although there are some concerns about it causing heart problems, until now few risk factors have been identified among patients in clinical trials, most of whom are usually younger than 70 years and have good general health.
Breast cancer drug raises risk of heart problems in older women 2011
-
The company said it hopes to file its breast-cancer drug Trastuzumab-DM1, or T-DM1, for regulatory approval by the end of the year.
Roche Looks to New Disease Areas Jeanne Whalen 2010
-
The company said it hopes to file its breast-cancer drug Trastuzumab-DM1, or T-DM1, for regulatory approval by the end of the year.
Roche Looks to New Disease Areas Jeanne Whalen 2010
-
The company said it hopes to file its breast-cancer drug Trastuzumab-DM1, or T-DM1, for regulatory approval by the end of the year.
Roche Looks to New Disease Areas Jeanne Whalen 2010
-
The company said it hopes to file its breast-cancer drug Trastuzumab-DM1, or T-DM1, for regulatory approval by the end of the year.
Roche Sees Big Potential in New Drugs Jeanne Whalen 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.